Skip to main content

Claritev Corp

corporate_fare Company Profile

Claritev Corp

CTEV·NYSE·Healthcare·CIK 0001793229

Claritev Corporation is a technology, data, and insights company that works to improve transparency, affordability, and quality within the healthcare system. Founded in 1980, Claritev applies over 45 years of claims and data experience, along with world-class technology and artificial intelligence (AI) solutions, to provide objective, market-based insights for complex healthcare decisions. The company helps organizations across the healthcare ecosystem understand costs, pricing, and payment dynamics. This enables more informed decision-making, reduces friction, and improves how the healthcare system operates, aiming for greater affordability, alignment, and long-term sustainability. Claritev addresses the increasing cost, risk, and complexity of healthcare in the United States. U.S. healthcare spending was projected to grow 7.1% in 2025 to $5.6 trillion, representing 18.5% of U.S. GDP, according to the Centers for Medicare and Medicaid (CMS). Healthcare spending is projected to grow by a compound annual growth rate of 5.4% annually from 2025 through 2033, exceeding the average GDP growth rate and reaching more than $8.6 trillion of total healthcare spending by 2033. Claritev's services focus on bringing transparency, competitive market efficiencies, utilization management, and billing and payment accuracy to the healthcare marketplace.

Claritev Corp (NYSE:CTEV) is a publicly traded company in the Healthcare sector. Wiseek monitors CTEV SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Claritev Responds to DOJ Criminal Antitrust Probe Allegations, Confirms Ongoing Investigation Since 2024
  • Claritev Reports Increased Q1 Net Loss, Higher Cash Burn, and Significant CEO Compensation Package
  • Claritev Reports Increased Q1 Net Loss and Worsened Free Cash Flow Despite Revenue Growth
  • Claritev Reports Significant $4.41 Per Share Loss in First Quarter
  • Claritev Seeks Shareholder Approval to Add 2.375 Million Shares to Equity Incentive Plan

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$965.41M
Net Income
-$284.28M
Diluted EPS
-$17.30
Op. Cash Flow
$117.32M
Free Cash Flow
-$12.28M
Operating Income
$28.77M
Cash & Equivalents
$16.81M
Total Debt
$14.69M
Debt / Equity
-0.08×
Net Margin
-29.4%
Shares Outstanding
16.55M sh
Source: 10-K · filed 2026-02-26 · accession 0001793229-26-000017
Browse all tickers starting with C →
$30.89
52-week range · as of 2026-05-18 $11.5 – $74.07
Market cap
$526.61M
Volume
128K (0.7× avg)
3-mo avg 184.5K
Live data · 2026-06-14 03:51 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CTEV - Latest Insights

CTEV
May 18, 2026, 12:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.71
Real-time Price: $30.89 info
Change: +$19.18 (+164%) info
Market Cap: $526.606M info
CTEV
May 07, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $24.21
Real-time Price: $30.89 info
Change: +$6.68 (+28%) info
Market Cap: $526.606M info
CTEV
May 07, 2026, 6:06 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.47
Real-time Price: $30.89 info
Change: +$4.42 (+17%) info
Market Cap: $526.606M info
CTEV
May 07, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $26.47
Real-time Price: $30.89 info
Change: +$4.42 (+17%) info
Market Cap: $526.606M info
CTEV
Mar 20, 2026, 6:45 AM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $15.51
Real-time Price: $30.89 info
Change: +$15.38 (+99%) info
Market Cap: $526.606M info
CTEV
Mar 20, 2026, 6:43 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $15.51
Real-time Price: $30.89 info
Change: +$15.38 (+99%) info
Market Cap: $526.606M info
CTEV
Mar 16, 2026, 5:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.60
Real-time Price: $30.89 info
Change: +$13.29 (+76%) info
Market Cap: $526.606M info
CTEV
Feb 26, 2026, 6:14 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $14.20
Real-time Price: $30.89 info
Change: +$16.69 (+118%) info
Market Cap: $526.606M info
CTEV
Feb 23, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.23
Real-time Price: $30.89 info
Change: +$7.66 (+33%) info
Market Cap: $526.606M info